Creating a quick test to detect a deadly brain-eating amoeba.

Development of a latex-agglutination assay for the rapid detection of Naegleria fowleri

NIH-funded research University of Texas Med Br Galveston · NIH-11056249

This study is working on a quick test that can help doctors find a harmful amoeba called Naegleria fowleri in spinal fluid in just 15 minutes, making it easier and faster to diagnose serious brain infections and potentially save lives.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Med Br Galveston NIH-funded
Lab location1 site (Galveston, United States)
Project IDNIH-11056249 on NIH RePORTER

What this research studies

This research focuses on developing a rapid latex-agglutination assay to detect Naegleria fowleri, a dangerous amoeba that can cause severe brain infections. The approach involves using antibodies derived from rabbits inoculated with the amoeba to create a test that can identify the presence of Naegleria fowleri in cerebrospinal fluid within 15 minutes. By comparing this new method to existing diagnostic techniques, the researchers aim to establish a faster and more efficient way to diagnose infections, potentially saving lives.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals, particularly children under 11 years old, who may be at risk for infections caused by Naegleria fowleri.

Not a fit: Patients who are not at risk for Naegleria fowleri infections or those who have already been diagnosed and treated may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to quicker diagnoses of Naegleria fowleri infections, allowing for timely treatment and improved patient outcomes.

How similar studies have performed: While rapid diagnostic tests for other pathogens have shown success, this specific approach for Naegleria fowleri is novel and untested.

Where this research is happening

Galveston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.